US$ 25.98
bpc-157 human studies clinical trials 2025 2026 ๐๐ปโโ๏ธ Is the lack of data in a red flag? โข If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury BPC-157: Top Peptide for Injury
Description
[DOI] [PubMed] [Google Scholar] 93.Xu J., Kim G.M., Ahmed S.H., Xu J., Yan P., Xu X.M., Hsu C.Y

PMID: 9547930
Therefore, this needs to be discussed in more detail

Side effects are rare and mild, usually limited to brief muscle soreness, local discomfort, or dizziness

Although it entered phase I clinical trials in this regard, BPC-157 is not certified by the US Food and Drug Administration (FDA) for medical use

Pike et al., 2000